Technical Analysis for MRSN - Mersana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.89 -2.75% -0.11
MRSN closed down 2.75 percent on Thursday, July 18, 2019, on 83 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MRSN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -2.75%
Bollinger Band Squeeze Range Contraction -2.75%
Narrow Range Bar Range Contraction -2.75%
Inside Day Range Contraction -2.75%

Older signals for MRSN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mersana Therapeutics, Inc. is a United States-based biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies. XMT-1522 is based on its Dolaflexin platform and has over 15 auristatin molecules per antibody. XMT-1522 is in Phase I clinical trial for various indications of cancers. XMT-1536 is in pre-clinical development.
Medicine Biotechnology Cancer Immunology Cancers Chemotherapy Monoclonal Antibodies Antibody Drug Conjugates Adc
Is MRSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.93
52 Week Low 2.845
Average Volume 285,283
200-Day Moving Average 5.274
50-Day Moving Average 4.461
20-Day Moving Average 4.0505
10-Day Moving Average 3.978
Average True Range 0.2352
ADX 12.84
+DI 12.6716
-DI 18.0368
Chandelier Exit (Long, 3 ATRs ) 3.6944
Chandelier Exit (Short, 3 ATRs ) 4.5656
Upper Bollinger Band 4.2372
Lower Bollinger Band 3.8638
Percent B (%b) 0.07
BandWidth 9.218615
MACD Line -0.1046
MACD Signal Line -0.1196
MACD Histogram 0.015
Fundamentals Value
Market Cap 88.35 Million
Num Shares 22.7 Million
EPS -16.23
Price-to-Earnings (P/E) Ratio -0.24
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.31
Resistance 3 (R3) 4.35 4.24 4.24
Resistance 2 (R2) 4.24 4.14 4.23 4.22
Resistance 1 (R1) 4.07 4.07 4.02 4.03 4.19
Pivot Point 3.96 3.96 3.94 3.95 3.96
Support 1 (S1) 3.79 3.86 3.74 3.75 3.59
Support 2 (S2) 3.68 3.79 3.67 3.56
Support 3 (S3) 3.51 3.68 3.54
Support 4 (S4) 3.47